Skip to main content
SpringerLink
Log in

High dose chemotherapy for the treatment of malignant brain tumors

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Conventional treatment of malignant high grade gliomas includes maximal resection followed by external beam radiotherapy. The addition of adjuvant chemotherapy has provided little improvement in the median duration of survival for these patients, particularly those patients with glioblastoma multiforme. The failure of conventional dose chemotherapy to improve the outcome of patients with high grade brain tumors has led several investigators to utilize high dose chemotherapy in order to overcome the limited benefit seen with conventional dose therapy which is due to intrinsic drug resistance as well as the impermeability of blood brain barrier. The majority of published studies utilizing this approach suggest that the addition of high dose chemotherapy with bone marrow transplant is of marginal benefit. However, most of these trials include small numbers of patients with advanced, refractory disease. A few trials have been reported utilizing high dose therapy in an adjuvant setting and the data from these studies are somewhat more promising. This review will analyze these studies and also discuss possible modifications of this approach in order to improve this aggressive treatment for patients who otherwise would have a dismal prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Boring CC, Squires TS, Tong T: Cancer statistics. CA Cancer J Clin 43: 7–26, 1993

    PubMed  Google Scholar 

  2. Lesser GJ, Grossman SA: The chemotherapy of adult primary brain tumors. Cancer Treat Rev 19: 261–81, 1993

    PubMed  Google Scholar 

  3. Kornblith PL, Walker M: Chemotherapy for malignant gliomas. J Neurosurg 68: 1–17, 1988

    PubMed  Google Scholar 

  4. Moynihan TJ, Grossman SA: The role of chemotherapy in the treatment of primary tumors of the central nervous system. Cancer Investigation 12: 88–97, 1994

    PubMed  Google Scholar 

  5. Petersdorf S, Upchurch C, Eyre Het al.: A phase II study of external beam radiation and chemotherapy with cisplatin/BCNU followed by BCNU alone for the treatment of incompletely resected high grade brain tumors: Preliminary results of a Southwest Oncology Group (SWOG) Study (SWOG 9016). Proc Am Soc Clin Oncol 12: 176, 1993 (abstr)

    Google Scholar 

  6. Greig NH: Optimizing drug delivery to brain tumors. Cancer Treat Rev 14: 1–28, 1987

    PubMed  Google Scholar 

  7. Blasberg RG, Groothuis DR: Chemotherapy of brain tumors: physiological and pharmacokinetic considerations. Semin Oncol 13(1): 70–82, 1986

    PubMed  Google Scholar 

  8. Phillips PC: Antineoplastic drug resistance in brain tumors. Neurol Clin 9: 383–404, 1991

    PubMed  Google Scholar 

  9. Sariban E, Kohn KW, Zlotogorski Cet al.: DNA cross-linking responses of human malignant glioma cell strains to chloroethylnitrosoureas, cisplatin, and diazequone. Cancer Res 47: 3988–3994, 1987

    PubMed  Google Scholar 

  10. Schluesener HJ: Multidrug transport in human glioblastoma cells is inhibited by transforming growth factors type beta 1, beta 2, and beta 1.2. J Neurosci Res 28: 310–314, 1991

    PubMed  Google Scholar 

  11. Janus TJ, Kyritsis AP, Forman ADet al.: Biology and treatment of gliomas. Ann Oncol 3: 423–433, 1992

    PubMed  Google Scholar 

  12. Cheson BD, Lacerna L, Leyland-Jones Bet al.: Autologous bone marrow transplantation. Current status and future directions. Ann Intern Med 110: 51–65, 1989

    PubMed  Google Scholar 

  13. Fine HA, Antman KH: High dose chemotherapy with autologous bone marrow transplantation in the treatment of high grade astrocytomas in adults: therapeutic rationale and clinical experience. Bone Marrow Transplant 10: 315–321, 1992

    PubMed  Google Scholar 

  14. Carella AM, Giordano D, Santini Get al.: High dose BCNU followed by autologous bone marrow infusion in glioblastoma multiforme. Tumori 67: 473–475, 1981

    PubMed  Google Scholar 

  15. Mortimer JE, Hewlett JS, Bay J: High dose BCNU with autologous bone marrow rescue in the treatment of recurrent malignant gliomas. J Neurooncol 1: 269–273, 1983

    PubMed  Google Scholar 

  16. Nomura K, Watanabe T, Nakamura Oet al.: Intensive chemotherapy with autologous bone marrow rescue for recurrent malignant gliomas. Neurosurg Rev 7: 13–22, 1984

    PubMed  Google Scholar 

  17. Hochberg FH, Parker LM, Takvorian Tet al.: High dose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiforme. J Neurosurg 54: 455–460, 1981

    PubMed  Google Scholar 

  18. Takvorian T, Parker LM, Hochberg FHet al.: Autologous bone-marrow transplantation: host effects of high-dose BCNU. J Clin Oncol 1: 610–620, 1983

    PubMed  Google Scholar 

  19. Phillips GL, Wolff SN, Fay JWet al.: Intensive 1,3-bis(2-chloroethyl)-l-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant glioma. J Clin Oncol 4: 639–645, 1986

    PubMed  Google Scholar 

  20. Hildebrand J, Badjou R, Collard-Ronge Eet al.: Treatment of brain gliomas with high doses of CCNU and autologous bone marrow transplantation. Biomedicine 32: 525–530, 1980

    Google Scholar 

  21. Giannone L, Wolff SN: Phase II treatment of central nervous system gliomas with high-dose etoposide and autologous bone marrow transplantation. Cancer Treat Rep 71: 759–761, 1987

    PubMed  Google Scholar 

  22. Leff RS, Thompson JM, Daly MBet al.: Acute neurologic dysfunction after high-dose etoposide therapy for malignant glioma. Cancer 62: 32–35, 1988

    PubMed  Google Scholar 

  23. Johnson DB, Thompson JM, Corwin JAet al.: Prolongation of survival for high-grade malignant gliomas with adjuvant high-dose BCNU and autologous bone marrow transplantation. J Clin Oncol 5: 783–789, 1987

    PubMed  Google Scholar 

  24. Wolff SN, Phillips GL, Herzig GP: High-dose carmustine with autologous bone marrow transplantation for the adjuvant treatment of high-grade gliomas of the central nervous system. Cancer Treat Rep 71: 183–185, 1987

    PubMed  Google Scholar 

  25. Mbidde EK, Selby PJ, Perren TJet al.: High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma. Br J Cancer 58: 779–782, 1988

    PubMed  Google Scholar 

  26. Ascensao J, Ahmed T, Feldman Eet al.: High dose thiotepa with autologous bone marrow transplantation (ABMT) and localized radiotherapy for patients with astrocytoma grade III/IV (glioma): a promising approach. Proc Am Soc Clin Oncol 8: 90, 1989

    Google Scholar 

  27. Kalifa C, Hartmann O, Demeocq Fet al.: High dose busulfan and thiotepa with autologous bone marrow transplantation in childhood malignant brain tumors: a phase II study. Bone Marrow Transplant 9: 227–233, 1992

    PubMed  Google Scholar 

  28. Finlay JL, August C, Packer Ret al.: High dose multi-agent chemotherapy followed by bone marrow ‘rescue’ for malignant astrocytomas of childhood and adolescence. J Neurooncol 9: 239–248, 1990

    PubMed  Google Scholar 

  29. Heideman RL, Douglass EC, Krance RAet al.: High dose chemotherapy and autologous bone marrow rescue followed by interstitial and external-beam radiotherapy in newly diagnosed pediatric malignant gliomas. J Clin Oncol 11: 1458–1465, 1993

    PubMed  Google Scholar 

  30. Teicher BA, Holden SA, Eder JPet al.: Influence of schedule on alkylating agent cytotoxicityin vitro andin vivo. Cancer Res 49: 5994–5998, 1989

    PubMed  Google Scholar 

  31. Horowitz ME, Kun LE, Mulhern RKet al.: Feasibility and efficacy of preirradiation chemotherapy for pediatric brain tumors. Neurosurgery 22: 687–690, 1988

    PubMed  Google Scholar 

  32. Kessinger A: High dose chemotherapy with autologous bone marrow rescue for high grade gliomas of the brain: a potential for improvement in therapeutic results. Neurosurgery 15: 747–750, 1984

    PubMed  Google Scholar 

  33. Longee DC, Friedman HS, Albright RE Jret al.: Treatment of patients with recurrent gliomas with cyclophosphamide and vincristine. J Neurosurg 72: 583–588, 1990

    PubMed  Google Scholar 

  34. Spence AM, Berger MS, Livingston RBet al.: Phase II evaluation of high dose intravenous cisplatin for treatment of adult malignant gliomas recurrent after chloroethyl nitrosourea failure. J Neurooncol 12: 187–191, 1992

    PubMed  Google Scholar 

  35. Yung WK, Mechtler L, Gleason MJ: Intravenous carboplatin for recurrent malignant gliomas: a phase II study. J Clin Oncol 9: 860–864, 1991

    PubMed  Google Scholar 

  36. Friedman HS: Personal communication, 1993

Download references

Author information

Authors and Affiliations

  1. Medical Oncology, University of Washington, Seattle, WA, USA

    Stephen H. Petersdorf

  2. Division of Medical Oncology, University of Washington, Seattle, WA, USA

    Robert B. Livingston

Authors
  1. Stephen H. Petersdorf
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert B. Livingston
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Petersdorf, S.H., Livingston, R.B. High dose chemotherapy for the treatment of malignant brain tumors. J Neuro-Oncol 20, 155–163 (1994). https://doi.org/10.1007/BF01052725

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01052725

Key words

Search

Navigation